Literature DB >> 32669318

Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems.

Nirupa R Ghai1, Christopher D Jensen2, Sophie A Merchant2, Joanne E Schottinger3, Jeffrey K Lee2, Jessica Chubak4, Aruna Kamineni4, Ethan A Halm5,6, Celette Sugg Skinner6, Jennifer S Haas7, Beverly B Green4, Nancy T Cannizzaro8, Jennifer L Schneider2, Douglas A Corley2.   

Abstract

Primary care provider's (PCP) perceptions of colorectal cancer screening test effectiveness and their recommendations for testing intervals influence patient screening uptake. Few large studies have examined providers' perceptions and recommendations, including their alignment with evidence suggesting comparable test effectiveness and guideline recommendations for screening frequency. Providers (n = 1,281) within four healthcare systems completed a survey in 2017-2018 regarding their perceptions of test effectiveness and recommended intervals for colonoscopy and fecal immunochemical testing (FIT) for patients ages 40-49, 50-74, and ≥75 years. For patients 50-74 (screening eligible), 82.9% of providers rated colonoscopy as very effective versus 59.6% for FIT, and 26.3% rated colonoscopy as more effective than FIT. Also, for this age group, 77.9% recommended colonoscopy every 10 years and 92.4% recommended FIT annually. For patients ages 40-49 and ≥75, more than one-third of providers believed the tests were somewhat or very effective, although >80% did not routinely recommend screening by either test for these age groups. Provider screening test interval recommendations generally aligned with colorectal cancer guidelines; however, 25% of providers believed colonoscopy was more effective than FIT for mortality reduction, which differs from some modeling studies that suggest comparable effectiveness. The latter finding may have implications for health systems where FIT is the dominant screening strategy. Only one-third of providers reported believing these screening tests were effective in younger and older patients (i.e., <50 and ≥75 years). Evidence addressing these beliefs may be relevant if cancer screening recommendations are modified to include older and/or younger patients. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 32669318      PMCID: PMC7641998          DOI: 10.1158/1940-6207.CAPR-20-0109

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  25 in total

1.  Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.

Authors:  Ethan A Halm; Elisabeth F Beaber; Dale McLerran; Jessica Chubak; Douglas A Corley; Carolyn M Rutter; Chyke A Doubeni; Jennifer S Haas; Bijal A Balasubramanian
Journal:  J Gen Intern Med       Date:  2016-06-08       Impact factor: 5.128

2.  Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.

Authors:  Andrew M D Wolf; Elizabeth T H Fontham; Timothy R Church; Christopher R Flowers; Carmen E Guerra; Samuel J LaMonte; Ruth Etzioni; Matthew T McKenna; Kevin C Oeffinger; Ya-Chen Tina Shih; Louise C Walter; Kimberly S Andrews; Otis W Brawley; Durado Brooks; Stacey A Fedewa; Deana Manassaram-Baptiste; Rebecca L Siegel; Richard C Wender; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2018-05-30       Impact factor: 508.702

3.  Primary Care Providers' Beliefs and Recommendations and Use of Screening Mammography by their Patients.

Authors:  Jennifer S Haas; William E Barlow; Marilyn M Schapira; Charles D MacLean; Carrie N Klabunde; Brian L Sprague; Elisabeth F Beaber; Jane S Chen; Asaf Bitton; Tracy Onega; Kimberly Harris; Anna N A Tosteson
Journal:  J Gen Intern Med       Date:  2017-01-09       Impact factor: 5.128

4.  A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial.

Authors:  Beverly B Green; Melissa L Anderson; Andrea J Cook; Jessica Chubak; Sharon Fuller; Richard T Meenan; Sally W Vernon
Journal:  Cancer       Date:  2017-07-28       Impact factor: 6.860

5.  Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines.

Authors:  Jennifer S Haas; Brian L Sprague; Carrie N Klabunde; Anna N A Tosteson; Jane S Chen; Asaf Bitton; Elisabeth F Beaber; Tracy Onega; Jane J Kim; Charles D MacLean; Kimberly Harris; Phillip Yamartino; Kathleen Howe; Loretta Pearson; Sarah Feldman; Phyllis Brawarsky; Marilyn M Schapira
Journal:  J Gen Intern Med       Date:  2016-01       Impact factor: 5.128

6.  Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network.

Authors:  Victoria S Benson; Wendy S Atkin; Jane Green; Marion R Nadel; Julietta Patnick; Robert A Smith; Patricia Villain
Journal:  Int J Cancer       Date:  2011-08-30       Impact factor: 7.396

7.  Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.

Authors:  Christopher D Jensen; Douglas A Corley; Virginia P Quinn; Chyke A Doubeni; Ann G Zauber; Jeffrey K Lee; Wei K Zhao; Amy R Marks; Joanne E Schottinger; Nirupa R Ghai; Alexander T Lee; Richard Contreras; Carrie N Klabunde; Charles P Quesenberry; Theodore R Levin; Pauline A Mysliwiec
Journal:  Ann Intern Med       Date:  2016-01-26       Impact factor: 25.391

8.  Physician-patient colorectal cancer screening discussions by physicians' screening rates.

Authors:  Cathleen M O'Farrell; Beverly B Green; Robert J Reid; Deborah Bowen; Laura-Mae Baldwin
Journal:  J Am Board Fam Med       Date:  2012 Nov-Dec       Impact factor: 2.657

9.  Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.

Authors:  Amit G Singal; Douglas A Corley; Aruna Kamineni; Michael Garcia; Yingye Zheng; Paul V Doria-Rose; Virginia P Quinn; Christopher D Jensen; Jessica Chubak; Jasmin Tiro; Chyke A Doubeni; Nirupa R Ghai; Celette Sugg Skinner; Karen Wernli; Ethan A Halm
Journal:  Am J Gastroenterol       Date:  2018-02-27       Impact factor: 10.864

10.  Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population.

Authors:  Theodore R Levin; Douglas A Corley; Christopher D Jensen; Joanne E Schottinger; Virginia P Quinn; Ann G Zauber; Jeffrey K Lee; Wei K Zhao; Natalia Udaltsova; Nirupa R Ghai; Alexander T Lee; Charles P Quesenberry; Bruce H Fireman; Chyke A Doubeni
Journal:  Gastroenterology       Date:  2018-07-19       Impact factor: 22.682

View more
  4 in total

1.  Perceived effectiveness of cancer screening among family medicine and internal medicine physicians in the United States.

Authors:  Trishnee Bhurosy; Michelle T Bover Manderski; Carolyn J Heckman; Nishi J Gonsalves; Cristine D Delnevo; Michael B Steinberg
Journal:  Prev Med Rep       Date:  2022-05-23

2.  Factors Associated With Clinician Recommendations for Colorectal Cancer Screening Among Average-Risk Patients: Data From a National Survey.

Authors:  Xuan Zhu; Emily Weiser; Debra J Jacobson; Joan M Griffin; Paul J Limburg; Lila J Finney Rutten
Journal:  Prev Chronic Dis       Date:  2022-04-14       Impact factor: 2.830

3.  Colorectal cancer screening preferences among physicians and individuals at average risk: A discrete choice experiment.

Authors:  Sebastian Heidenreich; Lila J Finney Rutten; Lesley-Ann Miller-Wilson; Cecilia Jimenez-Moreno; Gin Nie Chua; Deborah A Fisher
Journal:  Cancer Med       Date:  2022-03-21       Impact factor: 4.711

4.  Differences in Breast and Colorectal Cancer Screening Adherence Among Women Residing in Urban and Rural Communities in the United States.

Authors:  Sanjay Shete; Yangyang Deng; Jackilen Shannon; Babalola Faseru; Deirdre Middleton; Ronaldo Iachan; Brittany Bernardo; Rajesh Balkrishnan; Sunny Jung Kim; Bin Huang; Morgan M Millar; Bernard Fuemmler; Jakob D Jensen; Jason A Mendoza; Jinxiang Hu; DeAnn Lazovich; Linda Robertson; Wendy Demark-Wahnefried; Electra D Paskett
Journal:  JAMA Netw Open       Date:  2021-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.